The Francis Crick Institute’s Post

Very excited to announce the new addition to my name: A/Prof Jennifer Zenker Thanks to my team and supporters (scientists and non-scientists) who were joining me on this journey, my promotion to A/Prof has been made possible. 5.5 years ago, I arrived at the Australian Regenerative Medicine Institute (at Monash University in Melbourne, Australia) with a dream. Since then, this dream has been transformed into a clear vision to uncover the intricate processes that govern the formation of life. Advancing our knowledge on how a new life is assembled, may pave the way for new possibilities to repair and regenerate diseased or injured body parts and organs. Together, the Zenker Lab published groundbreaking papers on cell fate regulation, cell biological mechanisms during early embryogenesis, and innovative imaging technologies for watching and manipulating development pathways in the embryo. Our research catapulted the Zenker Lab onto the international stage, allowing me to take on various leadership roles, securing highly competitive funding for the continuous growth of the Zenker Lab, invitations to speaker opportunities across the world and most importantly, allowing me to provide young talented scientists of tomorrow a path to fulfill their dreams. But it hadn’t been easy. Long hours, countless writing tasks for me and countless experiments for my lab members, and the inevitable setbacks had been part of the journey. Through perseverance and an unlimited passion for my work as a scientist and leader, we achieved all critical milestones that seemed unimaginable at the start. My promotion to A/Prof marks one of the biggest milestones in my career thus far, but I also know that it is just the beginning of the next chapter. In the years to come, I will guide the Zenker Lab to continue to push the boundaries of knowledge in regenerative and reproductive medicine. Each new discovery may bring us closer to our ultimate goal: a future where damaged tissues and organs can be repaired, replaced, or even regenerated, thanks to a deeper understanding of how life begins and develops from a single cell – the fertilised egg. To turn uncertainty into hope. Footnote to picture: Taken at the annual conference of the Adora IVF &Fertility clinics last month. It was a fantastic conference where I was invited as a speaker to update clinicians & nurses about the current science in the field. What cannot be seen on this picture is that this day started for me at 04.00am as I had a 170km bike ride plus 40min run off the bike on my schedule before spending the day at the conference…

The Final Conference video is now live! Couldn't attend, or want to remember the nice time we all had in Brittany? Check it out here: https://lnkd.in/eZVtWjxp #research #phd #REE #science #toxicology #geology #modelling #MSCA #horizon2020 #ITN

Mission and vision

I #insideTRON I Today, we would like to introduce Cristian Raileanu, who joined our Vectors Unit headed by Tim Beissert in mid-January 2022 following his post-doc at the Friedrich Loeffler Institute on the Isle of Riems 👨⚕️. The most rewarding challenge of his daily work is to navigate between multiple tasks. Read about his motivation to join TRON and his research in his short interview below 👇 #TRONMainz #translationalscience #viralvectors #onehealth

Check out this exciting new paper leveraging CIVO from Presage Biosciences, Inc. and spatial profiling from NanoString Technologies, Inc. to asses, in situ, the effect of subasumstat on head and neck carcinoma 🔬 Congratulations to all the authors, and we are glad that #HALOimageanalysis assisted with biomarker quantification in your IHC! #spatialbiology #digitalpathology #CIVO #Takeda #IndicaLabs

Looking to maximize efficacy of your screening cascades and identify tractable hits quickly? Join us September 26 in at the Magdalen Centre at the The Oxford Science Park (TOSP) for our Hit Finding Lunch & Learn. Eurofins Discovery’s expert, Céline Legros, PhD, will be presenting Hit-Finding techniques, how they can be combined with PROTAC® approaches, plus further innovative technologies. Agenda 12-1 pm 🕛 Welcome / Session 1: Conventional Hit Finding, Combined with PROTAC Approaches 1-2 pm 🕐 Lunch & Networking 2-3 pm 🕑 Session 2: Innovative Technologies 3-4 pm 🕒 Coffee & 1:1 Networking 4 pm 🕓 Close of Day   Deepen your knowledge in Hit-Finding techniques from #HTS to extended hit characterization and learn about how they can be combined with #PROTAC approaches. Understand how by using different innovative technologies, it is possible to accelerate the identification of new hits. Contact us to register free of charge (HitFinding@eurofins.com) and schedule a 1:1 meeting with Dr. Legros and the team to discuss your project. #hitfinding #drugdiscovery #PIM3 #eurofins 

اعلام پوزیشن تحصیلی در مقطع پستداک در Department of Biomedical Sciences, University of Illinois at Chicago, America حیطه فعالیت استاد به صورت کلی: One of the directions of his laboratory is development of novel tools for interrogation of signaling pathways in living cells. He employs protein engineering approaches to gain control of individual proteins, reconstruct and manipulate specific signaling pathways, and build artificial signaling networks. These innovative technologies allow they to overcome limitations of existing methods and tackle scientific problems from a different perspective. جهت کسب اطلاعات بیشتر و تماس با استاد به وبسایت زیر مراجعه نمایید: https://lnkd.in/edrCQ2vK #postdoctoralposition #phd2024 #postdocopportunities #fullfund #fullyfundedscholarships #opportunities #postdoctoralfellowship #academicresearch #biomolecular #biomedicalresearch #biomedicalopportunities #university #science #pharmacology #protienengineering

Congratulations to my colleague Eugene Przespolewski PharmD BCOP DPLA and Clinical Services Director Grazyna Riebandt, PharmD, BCOP for this recent publication shedding light on the challenges faced by Oncology Residency Program Directors (ORPDs) regarding protected administrative time and burnout. I have read a couple of studies about burnout among pharmacists lately. This study suggested that ASHP Residency Standards may not be meeting the needs of ORPDs, with 50.8% feeling that the current standard falls short. Only 5.2% of ORPDs had budgeted protected time as well as financial incentives. Fifty percent of respondents saying protected time was the most important change in improving well-being. The findings underscore the need for greater support and incentives for ORPDs. #Healthcare #ResidencyTraining #WellBeing #Burnout

🎉 🎉 Celebrating Episode 2️⃣ 0️⃣ of #BioBlast!! Devin Zitelman is joined by leaders and executives in life #science and biotech to discuss their career journey to the C-suite, market trends, #business strategies, tech commercialization, #capital raising, and more. The latest episode ft. Jeff Galvin, CEO, American Gene Technologies® International Inc. and Addimmune™, companies developing next generation cell and gene therapies for infectious diseases, cancers, and inherited disorders. Their proprietary delivery platform has enabled the company to raise significant #venture investment while transforming #patient care. ✈ His career journey from a #software engineer in Silicon Valley and early-retirement to commercializing a portfolio of patented technologies. Plus, how those early experiences impact his decision making and developing culture. 👨🔬 Approaching clinicals, including Phase I safety and efficacy, in alignment with patient's condition for cell and gene therapies while obtaining investments for future trials. 💻 Future implications for #AI and #ML technologies on molecular model development and where we are in the adoption as an industry relative to some of the LLMs that are currently available. Tune in by clicking the link below ⬇ and be sure to subscribe! Now streaming wherever you get your #podcast.

Prepared for my poster presentation at #MSMilan2023! Excited to share our research on tolerogenic dendritic cell treatment in MS. Looking forward to insightful discussions & connecting with fellow researchers 💬🤝🏽💡. #MS #msresearch